|
|
|
|
|
|
|
|
|
|
Blogger's Note: of relevance - Jan 31st, 2013 - NICE declined the use of Avastin for ovarian cancer patients in the UK
British Journal of Cancer - Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival
"...International comparisons show wide differences in cancer survival between high-income countries with good cancer registration systems and good access to health care (Berrino et al, 2007; Coleman et al, 2008). The International Cancer Benchmarking Partnership (ICBP) was set up to examine and explain survival differences between Australia, Canada, Denmark, Norway, Sweden and the UK. For cancers of the lung, breast, bowel and ovary diagnosed in 1995–2007, Australia, Canada and Sweden had the highest survival and Denmark and the UK the lowest; Norway had intermediate survival (Coleman et al, 2011)........
"We aimed to examine whether people living in countries with lower cancer survival (UK, Denmark) had lower cancer awareness, more negative beliefs about cancer or more barriers to symptomatic presentation than people in countries with higher cancer survival (Australia, Canada, Sweden)."
* see ovarian cancer referenced material:
Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G (2012) Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol 127(1): 75–82 | Article | PubMed |
* see blog post:
Wednesday, January 30, 2013
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.